C
$ Value
—
Shares
12,500
Price
—
Filed
Nov 12
Insider
Name
Drew Janice Suzann
Title
EVP, Operations
CIK
0002091053
Roles
Officer
Transaction Details
Transaction Date
2025-11-07
Code
C
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
—
Footnotes
Each share of Series B Preferred Stock automatically converted into shares of Common Stock immediately prior to the closing of the Issuer's initial public offering for no additional consideration on a 1-for-7.8721 basis and had no expiration date.
Filing Info
Drew Janice Suzann's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-16 | EVMN | A | $0 |
| 2025-12-09 | EVMN | F | $91K |
| 2025-11-07 | EVMN | C | — |
| 2025-11-07 | EVMN | C | — |
| 2025-11-05 | EVMN | A | $0 |
Other Insiders at EVMN (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | — | — | 2026-02-17 |
|
Pena Luis C.
President & CEO
|
— | — | 2026-04-16 |
|
Bauer Eugene
Chief Medical Officer
|
— | — | 2026-04-16 |
|
Moss Gregory S.
Chief Business & Legal Officer
|
— | — | 2026-04-16 |
|
Carver Kyle
Chief Financial Officer
|
— | — | 2026-04-16 |
| LSP 7 Cooperative UA | — | — | 2026-02-17 |
|
Drew Janice Suzann
Chief of Dev. Operations
|
— | — | 2026-04-16 |
|
Patel Jeegar Pravinkumar
Chief Scientific Officer
|
— | — | 2026-04-16 |
| Verduyn-van Weegen Felice Isabel | — | — | 2026-02-17 |